All Posts

U.S. equities extended their rebound on Thursday, June 18, 2026, as investors leaned back into cyclicals and AI-linked tech on growing confidence that the U.S.–Iran peace framework will stick and keep the Strait of Hormuz open. The S&P 500 climbed roughly 1.08%, the Nasdaq outperformed with gains north of 1.91%, and the Dow added +.14%, trading near record territory as energy inflation fears eased and the chip trade reignited. AI and semiconductor names led the advance, with Intel (INTC, $133.99,
(+10.64%) surging more than 10% after Washington spotlighted a reported Apple (AAPL, $298.01, +.70%) partnership—fueling a broader rally in Micron, Nvidia (NVDA, 210.69, +2.95%), AMD (AMD, $537.37, +4.86%), and other chipmakers as investors rotated back into the AI hardware backbone trade. The risk-on tone came despite a still‑hawkish Fed rate path, underscoring that for now, geopolitics and growth prospects are outweighing lingering policy uncertainty.

Macro Backdrop: Warsh Wants Markets To Lead

The macro narrative is being reshaped by new Fed Chair Kevin Warsh, who has kept policy rates on hold but signaled a willingness to tolerate more two‑way market moves by stepping away from traditional forward guidance. The latest Fed projections still point to the possibility of at least one rate hike later this year, yet Warsh is pushing markets to focus less on the dot plot and more on real‑time data on jobs, prices, and productivity. That stance is landing in a labor market that remains reasonably resilient but no longer red‑hot, with weekly jobless claims hovering in the low‑ to mid‑200,000s and showing mild softening versus earlier in the cycle. In practice, the combination of a cautious but not panicked Fed and a cooling‑but‑not‑cracking labor backdrop is encouraging equity investors to treat pullbacks as buying opportunities rather than the start of a new recessionary leg.

Energy, Gas, and Mortgages: Inflation Pressure Finally Bending

The U.S.–Iran deal to reopen the Strait of Hormuz and wind down the conflict is beginning to flow through to energy markets, with oil prices retreating and gasoline slipping below 4 dollars per gallon on average for the first time since March. AAA data now show national pump prices hovering just under that 4‑dollar threshold, helped by a roughly mid‑teens percentage drop in crude prices over the month as supply risk premia compress. Those moves are easing headline inflation pressure and starting to filter into interest‑sensitive pockets of the real economy, where mortgage rates have edged lower alongside reduced geopolitical risk and a modest pullback in long‑term yields. For households, that combination—cheaper fuel and slightly better financing terms—offers a small but meaningful boost to real disposable income heading into the back half of the year, bolstering the soft‑landing narrative that equity bulls are embracing.

Market Narrative: AI Chips, Peace Dividend, and a New Fed Playbook

Thematically, the tape is being driven by three intersecting narratives: an AI‑chip “second wind,” a nascent “peace dividend” from the Iran deal, and a Fed that wants markets to rediscover price discovery. Intel’s turnaround story—now reinforced by the reported Apple deal—has become a poster child for this mix, combining geopolitical alignment (onshoring and secure supply chains), AI infrastructure demand, and renewed investor confidence in legacy semis. At the same time, the easing in energy prices from the Hormuz agreement is lowering the tail risk of another inflation flare‑up, allowing growth and quality tech to reassert leadership without the same fear of a policy shock from the Fed. Warsh’s push to let data, not guidance, steer markets means that each print on jobs, inflation, and activity will matter more—an environment that tends to reward active investors and tactical positioning over passive set‑and‑forget exposure.

---

VP Watchlist Updates

Smartbird, Inc. (NASDAQ: BIRD, $5.97, +8.94%), an AI infrastructure provider, today announced the appointment of Nadia Carlsten as president and chief executive officer. Carlsten has also joined Smartbird’s board of directors. The company has completed its previously announced definitive agreement to sell the Allbirds brand and footwear assets. With the transition to Smartbird now completed, the company also strengthened its balance sheet by increasing the size of its convertible financing facility from $50 million to $100 million. The expanded capital base provides Smartbird with additional resources to execute its AI infrastructure strategy. A visionary and builder, Carlsten brings decades of deep technical expertise in AI compute infrastructure combined with commercial execution across platform scaling, go-to-market, partnerships and capital strategy. She has served as a trusted partner to boards and investors, with a strong track record of building high-performing teams, stewarding capital and generating strong returns on investment.

Eupraxia Pharmaceuticals Inc. (EPRX, $6.48, +3.02%), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, announced (May 5) the first Eosinophilic Esophagitis Endoscopic Reference Score (EREFS) data from its ongoing Phase 1b/2a part of the RESOLVE trial evaluating EP-104GI for the treatment of eosinophilic esophagitis (“EoE”). These data were also presented at the ongoing Digestive Disease Week (“DDW”) conference in Chicago. “The EREFS is an important, validated visual index of severity of EoE disease in the esophagus of patients. It measures edema, rings and strictures and other visible markers of disease often associated with symptoms. Today’s data demonstrated improvement in two key outcomes with EP-104GI in the treatment of EoE: first, that a full injection protocol of 20 injections resulted in more pronounced improvement than a protocol with fewer injections and less coverage area within the esophagus; second, with the higher number of injections, a consistent response in both the inflammatory and fibrotic sub scores of EREFS was observed,” said Dr. James A. Helliwell, Chief Executive Officer of Eupraxia. “This EREFS data being reported at DDW is consistent with the improvements we have seen in EoE symptoms and tissue health (EoEHSS) and suggests improvement in inflammation, fibrosis and the associated narrowing of the esophagus.”

Modular Medical, Inc. (NASDAQ:MODD, $5.15, +15.47%), a leader in innovative, patient-centric insulin delivery, announced (June 4) the launch of PivotPump.com, a patient-focused website designed to support individuals seeking a simpler path to insulin pump therapy. This launch follows the Company’s receipt of U.S. Food and Drug Administration (“FDA”) clearance in April 2026 for its Pivot™ insulin delivery system. The FDA clearance represents a significant milestone in Modular Medical’s strategy to expand access to insulin pump technology, particularly among individuals historically underserved by existing solutions. The Company remains on track for commercial launch in the fall of 2026. Pivot is designed for people living with diabetes who rely on daily insulin injections, as well as those who have encountered technological, usability, or cost-related barriers with traditional pump systems. The system emphasizes simplicity and ease of use for the patient and full access to clinical information for the clinician to reduce adoption friction. The PivotPump.com website provides accessible, educational content on insulin pump therapy and highlights the Company’s focus on real-world usability and supporting patients in evaluating and adopting pump-based diabetes care.

The Sources

1. CNBC – U.S. stock market live updates (June 17–18, 2026)
   https://www.cnbc.com/2026/06/17/stock-market-today-live-updates.html
2. Yahoo Finance – Stock market live: Dow, S&P 500, Nasdaq rally amid Iran deal optimism and AI chip trade
   https://finance.yahoo.com/markets/live/stocks-market-today-dow-sp-500-nasdaq-rally-amid-iran-deal-optimism-as-ai-chip-trade-reignites-230530576.html
3. Yahoo Finance – Intel stock soars on reported Apple deal as turnaround continues
   https://finance.yahoo.com/technology/article/intel-stock-soars-on-reported-apple-deal-as-turnaround-continues-to-pay-off-143423447.html
4. Yahoo Finance – U.S. ends Hormuz blockade and downplays tensions
   https://finance.yahoo.com/energy/articles/us-ends-hormuz-blockade-downplays-172504882.html
5. Yahoo Finance – Mortgage rates dropped this week as Iran peace deal took shape (rates today, June 18, 2026)
   https://finance.yahoo.com/personal-finance/mortgages/article/mortgage-rates-dropped-this-week-as-iran-peace-deal-took-shape-mortgage-and-refinance-interest-rates-today-june-18-2026-100000045.html
6. Yahoo Finance – Gas prices fall below $4 per gallon as oil loses steam
   https://finance.yahoo.com/markets/article/gas-prices-fall-below-4-per-gallon-as-oil-loses-steam-132647555.html
7. Yahoo Finance – U.S. weekly jobless claims fall
   https://finance.yahoo.com/news/us-weekly-jobless-claims-fall-124238903.html
8. Yahoo Finance – Warsh wants markets to guide the Fed, not the other way around
   https://finance.yahoo.com/economy/policy/article/warsh-wants-markets-to-guide-the-fed-not-the-other-way-around-190514731.html

All three major U.S. equity benchmarks finished in the red on Wednesday, June 17, 2026, as post‑Fed volatility, profit‑taking in AI and growth leaders, and renewed macro uncertainty pressured risk assets into the close. What began as a rotation‑heavy tape with a firmer Dow gave way to broad‑based selling by the bell, leaving the Dow, S&P 500, and Nasdaq all lower on the day.

---

Closing snapshot: all majors lower

• The S&P 500 slipped into the close, giving back earlier attempts to stabilize around recent highs as sellers leaned on mega‑cap tech and high‑multiple growth.
• The Dow, which had traded near record territory intraday, reversed to finish modestly lower as cyclical, industrial, and financial names lost steam once the Fed headlines cleared.
• The Nasdaq underperformed into the bell, as profit‑taking in AI, semiconductors, and software compounded the broader risk‑off tone and erased early rebound efforts.

By day’s end, the tape had transitioned from “Dow up, growth down” to a more classic risk‑off pattern where selling pressure was broad and liquidity thinned into the close.

---

Fed decision: no cut, but plenty of volatility

The FOMC held the federal funds rate steady in the 3.5%–3.75% range, in line with expectations, but the market response made clear that the details of the statement and projections mattered more than the headline hold. Policymakers reiterated that inflation progress has been “uneven,” and the updated dots continued to signal only a very shallow easing path, reinforcing the higher‑for‑longer narrative that has been weighing on duration‑sensitive assets. During Chair Powell’s press conference, repeated references to upside inflation risks and the need for “more confidence” before cutting rates catalyzed a late‑session fade across equities. Rate‑sensitive pockets such as growth tech, small caps, and real estate bore the brunt, but the message was broad enough to pull cyclicals lower as well, as investors contemplated a policy stance that stays restrictive deeper into 2026.

---

Macro data: growth looks fine, margin for error doesn’t

The day’s data did little to resolve the tension between solid near‑term activity and a more constrained policy backdrop. May retail sales painted a picture of a consumer that is still spending but increasingly selective, with strength concentrated in services and experiences while goods categories remained mixed. That supports the soft‑landing narrative but also suggests less room for fiscal or monetary missteps as excess savings shrink and credit metrics slowly deteriorate. Housing indicators—including pending home sales and inventory metrics—continued to show a sector adjusting to higher mortgage rates rather than buckling under them, with volumes subdued but not collapsing. For the Fed, that combination of okay‑ish growth and sticky shelter inflation is precisely what argues for patience, which in turn keeps the hurdle high for a dovish pivot that would re‑expand equity multiples.

---

Inflation and global cross‑currents

Global inflation and growth signals remained mixed. In Europe, softer headline inflation in recent prints has encouraged the view that the ECB can maintain a more balanced stance, helping European indices hold up relatively better earlier in the week even as U.S. markets churned. However, patchy industrial data and lingering political risk, especially around fiscal paths and elections, kept foreign flows cautious into today’s U.S. close. In Asia, stronger‑than‑expected export data out of Japan, particularly in autos and chips, underscored how AI‑related demand and supply‑chain realignment continue to underpin parts of the region. Yet Chinese growth concerns and uneven policy support kept a lid on risk appetite, feeding into the global risk‑off tone that ultimately dominated U.S. trading into the bell.

---

AI, tech, and the growth unwind

AI and broader tech remained the structural bull narrative but acted as the funding source for risk reduction today. High‑multiple AI infrastructure, semiconductor, and cloud names, which had carried the tape higher for much of 2026, saw concerted de‑risking as investors recalibrated valuation frameworks to a shallower and later easing cycle. The post‑Fed move looked less like a wholesale rejection of the AI theme and more like position‑trimming in names where expectations and positioning were most extended. Factor‑wise, both high‑beta and long‑duration names underperformed, while defensive quality and low‑volatility factors outperformed on a relative basis even as they finished modestly lower in absolute terms. That pattern is consistent with prior higher‑for‑longer repricings and suggests that investors were managing risk rather than capitulating on the core AI and digital‑infrastructure thesis.

---

Credit, commodities, and the dollar confirm risk‑off

Oil prices ($75.36/bbl) eased off their recent highs by the close as traders weighed the growth implications of prolonged restrictive policy against supply risks, taking some immediate pressure off the headline inflation trajectory. Even so, the absolute level of crude remains elevated enough that energy’s role as both an inflation wild card and a portfolio hedge is intact going into the next set of CPI and PCE prints. The U.S. dollar stayed firm, reflecting both policy‑rate differentials and a modest flight to safety, while credit spreads widened only marginally, signaling controlled risk‑off rather than stress. That restraint in credit is important: as long as funding markets remain orderly, equity corrections around Fed days are more likely to be absorbed as volatility events than as early signals of a systemic downturn.

---

Takeaways

For investors, today’s close reinforces several key messages:

• The policy put is further out of the money than many hoped, with the Fed signaling a preference to risk a bit more growth weakness over re‑accelerating inflation.
• The AI and growth complex remains the market’s primary shock absorber on hawkish days, making position sizing and entry discipline critical even if the long‑term thesis is intact.
• Quality balance sheets, durable cash flows, and pricing power retain a premium as the market internalizes a longer stretch of real yields that are positive and persistent.

VP Watchlist Updates

Smartbird, Inc. (NASDAQ: BIRD, $5.48, +39.09%), an AI infrastructure provider, today announced the appointment of Nadia Carlsten as president and chief executive officer. Carlsten has also joined Smartbird’s board of directors. The company has completed its previously announced definitive agreement to sell the Allbirds brand and footwear assets. With the transition to Smartbird now completed, the company also strengthened its balance sheet by increasing the size of its convertible financing facility from $50 million to $100 million. The expanded capital base provides Smartbird with additional resources to execute its AI infrastructure strategy. A visionary and builder, Carlsten brings decades of deep technical expertise in AI compute infrastructure combined with commercial execution across platform scaling, go-to-market, partnerships and capital strategy. She has served as a trusted partner to boards and investors, with a strong track record of building high-performing teams, stewarding capital and generating strong returns on investment.

Eupraxia Pharmaceuticals Inc. (EPRX, $6.29, +4.31%), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, announced (May 5) the first Eosinophilic Esophagitis Endoscopic Reference Score (EREFS) data from its ongoing Phase 1b/2a part of the RESOLVE trial evaluating EP-104GI for the treatment of eosinophilic esophagitis (“EoE”). These data were also presented at the ongoing Digestive Disease Week (“DDW”) conference in Chicago. “The EREFS is an important, validated visual index of severity of EoE disease in the esophagus of patients. It measures edema, rings and strictures and other visible markers of disease often associated with symptoms. Today’s data demonstrated improvement in two key outcomes with EP-104GI in the treatment of EoE: first, that a full injection protocol of 20 injections resulted in more pronounced improvement than a protocol with fewer injections and less coverage area within the esophagus; second, with the higher number of injections, a consistent response in both the inflammatory and fibrotic sub scores of EREFS was observed,” said Dr. James A. Helliwell, Chief Executive Officer of Eupraxia. “This EREFS data being reported at DDW is consistent with the improvements we have seen in EoE symptoms and tissue health (EoEHSS) and suggests improvement in inflammation, fibrosis and the associated narrowing of the esophagus.”

Modular Medical, Inc. (NASDAQ:MODD, $4.46), a leader in innovative, patient-centric insulin delivery, announced (June 4) the launch of PivotPump.com, a patient-focused website designed to support individuals seeking a simpler path to insulin pump therapy. This launch follows the Company’s receipt of U.S. Food and Drug Administration (“FDA”) clearance in April 2026 for its Pivot™ insulin delivery system. The FDA clearance represents a significant milestone in Modular Medical’s strategy to expand access to insulin pump technology, particularly among individuals historically underserved by existing solutions. The Company remains on track for commercial launch in the fall of 2026. Pivot is designed for people living with diabetes who rely on daily insulin injections, as well as those who have encountered technological, usability, or cost-related barriers with traditional pump systems. The system emphasizes simplicity and ease of use for the patient and full access to clinical information for the clinician to reduce adoption friction. The PivotPump.com website provides accessible, educational content on insulin pump therapy and highlights the Company’s focus on real-world usability and supporting patients in evaluating and adopting pump-based diabetes care.

uniQure N.V. (NASDAQ: QURE, $48.16, +78.44%), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that, during a recent Type B meeting with the U.S. Food and Drug Administration (FDA), the FDA communicated that the 3-year analysis from the Phase I/II study would be acceptable as the primary basis of a Biologics License Application (BLA) for the accelerated approval of AMT-130 in Huntington’s disease. In addition, the FDA seeks to align on the confirmatory study design prior to the BLA submission, including consideration of concurrent control on standard-of-care therapy instead of a sham procedure. FDA communicated that they would work as expeditiously as possible with uniQure on this effort. The Company is committed to conducting the confirmatory study without delay and expects to further align with the FDA on the details of such a study prior to BLA submission. The Company intends to submit the BLA in the third quarter of 2026.

Maase Inc. (NASDAQ: MAAS, $17.94, +12.97%) an integrated provider and operator of an AI-centric full-scene digital systems, announced (June 15) that its subsidiary, Huazhi Future (Chongqing) Technology Co., Ltd. (“Huazhi Future”) has formally established a green energy infrastructure research team. The research team designates 800-volt direct current (“800VDC”), a key standard within high-voltage direct current (“HVDC”) architectures, as its strategic research priority, focusing on scalable deployment pathways for 800VDC in intelligent computing centers, next-generation industrial parks, and distributed renewable energy integration scenarios.

Global herbicides are quietly becoming one of Wall Street’s more durable growth stories, and the latest FMC Corporation (FMC, $11.98, +3.28%) –Corteva (CTVA, $77.37, +0.65%) deal suggests this is a weed problem investors may actually want more of. The combination of steady market expansion, rising resistance to old chemistries, and capital‑light licensing economics is creating an underappreciated structural tailwind in crop protection

The Sources

1. Yahoo Finance – U.S. Markets Overview (intraday and closing levels, sector performance)
   https://finance.yahoo.com
2. Yahoo Finance – S&P 500 Historical Data (daily close for June 17, 2026)
   https://finance.yahoo.com/quote/%5EGSPC/history/
3. Trading Economics – United States Stock Market Index Quotes (context on index moves)
   https://tradingeconomics.com/united-states/stock-market
4. Wells Fargo Investment Institute – Stock Market News / Daily Opening & Market Comment
   https://www.wellsfargoadvisors.com/research-analysis/commentary/stock-market-news.htm
5. CNBC – “Stock market today: Live updates” (Fed‑day color, sector and macro commentary)
   https://www.cnbc.com/2026/06/16/stock-market-today-live-updates.html
6. Kiplinger – “June Fed Meeting: Live Updates and Commentary” (Fed statement and reaction)
   https://www.kiplinger.com/news/live/fed-meeting-updates-and-commentary-june-2026
7. Yahoo Finance / Fed coverage – “Interest rates steady, Federal Reserve holds rates…”
   https://finance.yahoo.com/news/live/fed-meeting-live-updates-federal-reserve-holds-rates-steady-forecasts-1-rate-cut-in-2026-180
8. BlackRock Investment Institute – Weekly Market Commentary (higher‑for‑longer, earnings backdrop)
   https://www.blackrock.com/us/individual/insights/blackrock-investment-institute/weekly-commentary
9. Carnegie Investment Counsel – “Monthly Market Commentary: June 2026” (AI‑driven leadership narrative)
   https://blog.carnegieinvest.com/monthly-market-commentary-june-2026
10. Reuters – “Nasdaq and S&P 500 slip while Dow hits record close” (recent context on Dow outperformance)
    https://www.reuters.com/business/wall-street-futures-subdued-focus-shifts-fed-spacex-jumps-third-day-2026-06-16/
11. The Star / The Straits Times – “Nasdaq, S&P 500 slip while Dow hits record close” (additional color on rotation)
    https://www.straitstimes.com/business/companies-markets/nasdaq-and-sp-500-slip-while-dow-hits-record-close
12. Yahoo Finance Live – Daily Market Coverage video (June 17, 2026 session color, intraday moves)
    https://www.youtube.com/watch?v=7ucAtBgT8DM

U.S. stocks ended Tuesday mixed, with the Dow extending its record run while the S&P 500 and Nasdaq moving lower as traders squared positions ahead of tomorrow’s Fed decision and parsed shifting headlines around a tentative U.S.–Iran deal and a still‑white‑hot SpaceX (SPCX, $201.80, +4.83%).

Closing snapshot: indexes and macro tone

• The Dow Jones Industrial Average (^DJI) finished near a fresh record, around 51,999.67, +.64%, as flows continued to favor value, financials, and select industrials tied to a post‑Iran‑war reopening and lower oil prices ($75.88,-4.48%).
• The S&P 500 (7,511.35, -.57%) and Nasdaq Composite (26,376.34,-1.15%), consolidating after Monday’s sharp rebound that had driven both toward recent highs alongside a collapse in crude and global yields after the U.S.–Iran peace framework.
• Under the surface, breadth was more muted than Monday’s surge, with traders rotating out of mega‑cap AI leaders and high‑beta software into cyclicals, energy beneficiaries of lower input costs, and stable cash‑flow compounders ahead of the Fed.
• The small caps on the Russell 2000 closed at 2,936.65, -.97%.

Macro sentiment remained cautiously risk‑on: falling oil, softer long‑end yields and still‑resilient credit spreads helped cushion equities even as investors braced for a potentially hawkish‑sounding Federal Reserve that is unlikely to cut rates in June.

Fed, inflation and the “Warsh put”

• Chair Kevin Warsh’s first full meeting has markets positioned for a hold, with Fed funds expected to remain in the 5.25%–5.50% range while the Committee updates its dot plot and narrative around still‑sticky core PCE running above 3%.
• Recent upside surprises in nonfarm payrolls and May CPI have re‑anchored the idea that “higher for longer” remains the base case, even as the Iran ceasefire and reopening of the Strait of Hormuz ease some supply‑side pressures via cheaper crude.
• For equity investors, tomorrow’s message is less about the actual rate decision and more about how Warsh frames growth versus inflation: a nod to moderating inflation and any hint of 2026 cuts could re‑ignite the AI and long‑duration growth trade, while a dots‑driven pushback could extend today’s mild de‑risking in high‑multiple tech.

In other central‑bank news, the Bank of Japan lifted its policy rate to the highest level since 1995 and the Reserve Bank of Australia stayed on hold after three hikes this year, underlining a gradual global shift away from emergency‑low policy settings even as growth remains uneven.

Sector movers: AI digestion, cyclicals firm

• Tech and AI: After a monster rebound in the Nasdaq of more than 3% on Monday, AI bellwethers such as Nvidia (NVDA), Advanced Micro Devices (AMD), Broadcom (AVGO) and other chip names saw profit‑taking, with investors already heavily positioned into the “AI infrastructure” theme.
• Software and cloud: Oracle (ORCL) traded heavy after investors raised concerns about the intensity of its AI infrastructure capex cycle and cash burn, a reminder that “AI spend” is a double‑edged sword for margins in the near term.
• Cyclicals and financials: Value‑tilted areas including large banks and industrials benefited from the reflation‑without‑recession narrative as oil retreated and the Iran‑Strait of Hormuz reopening story supported global trade sentiment.

Commodities and rates reinforced the cautious‑optimism tone: crude slipped as optimism grew for a durable U.S.–Iran agreement, while gold caught a modest safe‑haven bid as some investors hedged the risk that Fed communications surprise hawkish.

SpaceX (SPCX): from blockbuster IPO to mega‑cap club

SpaceX remained at the center of market storytelling, extending its post‑IPO surge and at times overtaking Amazon.com (AMZN) in market capitalization during today’s trade.

• Following its historic IPO — the largest equity offering in history — SpaceX shares jumped roughly 19% on debut and added another 6% in early trading Monday, before tacking on additional gains today as investors embraced its vertically integrated launch, satellite and space‑infrastructure platform.
• Pre‑market commentary highlighted SpaceX rallying for a third straight session, with the stock at one point up about 10% today, underscoring voracious demand from both institutional and retail accounts pivoting into pure‑play “space and sovereign AI infrastructure” exposure..
• Strategically, the Street is already tying SpaceX’s Starlink and data‑transport footprint to broader AI compute themes, including deals like Google’s recent purchase of capacity from SpaceX to support cloud and AI workloads — a narrative that keeps SPACE squarely in the same conversation as Nvidia (NVDA), Microsoft (MSFT), Alphabet (GOOGL), and other AI platform names.

For now, SpaceX is functioning as both a sentiment barometer and a liquidity magnet: its ability to hold post‑IPO gains could influence flows across tech, AI, and even high‑beta growth ETFs in the coming weeks.

Looking ahead: key investor questions

• Does the U.S.–Iran memorandum translate into a durable peace that caps crude and stabilizes global shipping, or will political skepticism at the G7 and divergent U.S./Iran narratives around the deal keep a volatility premium embedded in energy and defense?
• Can the Fed credibly keep rates elevated while growth wobbles at the margin, or will rising financial‑conditions sensitivity in AI and long‑duration tech force a more dovish signaling by late 2026?
• Will SpaceX’s mega‑cap ascent crowd out flows from other high‑growth tech leaders, or does its listing expand the overall risk‑budget and pull incremental capital into the public equity opportunity set?

From a positioning standpoint, today’s tape still rewards disciplined barbell exposure: quality cyclicals and cash‑rich value on one side, and genuinely cash‑generative AI and infrastructure leaders on the other, with careful sizing in more speculative software and space names as the Fed and geopolitics dictate the next leg.

VP Watchlist Updates

Netflix (NFLX) is said to be weighing a potential takeover of film and television producer Lionsgate Studios (LION, $16.36, +13.85%), sending Lionsgate shares sharply higher while Netflix shares traded lower on the report.

According to Semafor, the streaming giant has renewed its hunt for acquisition targets after its unsuccessful attempt to buy Warner Bros. Discovery (WBD). Earlier this year, Paramount Skydance (PSKY) is reported to have beaten out Netflix in the bidding for Warner Bros. Discovery.

Eupraxia Pharmaceuticals Inc. (EPRX, $6.03), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, announced (May 5) the first Eosinophilic Esophagitis Endoscopic Reference Score (EREFS) data from its ongoing Phase 1b/2a part of the RESOLVE trial evaluating EP-104GI for the treatment of eosinophilic esophagitis (“EoE”). These data were also presented at the ongoing Digestive Disease Week (“DDW”) conference in Chicago. “The EREFS is an important, validated visual index of severity of EoE disease in the esophagus of patients. It measures edema, rings and strictures and other visible markers of disease often associated with symptoms. Today’s data demonstrated improvement in two key outcomes with EP-104GI in the treatment of EoE: first, that a full injection protocol of 20 injections resulted in more pronounced improvement than a protocol with fewer injections and less coverage area within the esophagus; second, with the higher number of injections, a consistent response in both the inflammatory and fibrotic sub scores of EREFS was observed,” said Dr. James A. Helliwell, Chief Executive Officer of Eupraxia. “This EREFS data being reported at DDW is consistent with the improvements we have seen in EoE symptoms and tissue health (EoEHSS) and suggests improvement in inflammation, fibrosis and the associated narrowing of the esophagus.”

Modular Medical, Inc. (NASDAQ:MODD, $4.91), a leader in innovative, patient-centric insulin delivery, announced (June 4) the launch of PivotPump.com, a patient-focused website designed to support individuals seeking a simpler path to insulin pump therapy. This launch follows the Company’s receipt of U.S. Food and Drug Administration (“FDA”) clearance in April 2026 for its Pivot™ insulin delivery system. The FDA clearance represents a significant milestone in Modular Medical’s strategy to expand access to insulin pump technology, particularly among individuals historically underserved by existing solutions. The Company remains on track for commercial launch in the fall of 2026. Pivot is designed for people living with diabetes who rely on daily insulin injections, as well as those who have encountered technological, usability, or cost-related barriers with traditional pump systems. The system emphasizes simplicity and ease of use for the patient and full access to clinical information for the clinician to reduce adoption friction. The PivotPump.com website provides accessible, educational content on insulin pump therapy and highlights the Company’s focus on real-world usability and supporting patients in evaluating and adopting pump-based diabetes care.

The Sources

1. Yahoo Finance – Live Market Coverage and Recap
   https://finance.yahoo.com/markets/live/stock-market-today-dow-hits-record-sp-500-nasdaq-slip-as-iran-deal-doubts-grow-and-fed-decision-looms-223512220.html
2. CNBC – “Stock Market Today” Live Updates
   https://www.cnbc.com/2026/06/15/stock-market-today-live-updates.html
3. Yahoo Finance – Dow Jones Industrial Average (^DJI) Historical Data
   https://finance.yahoo.com/quote/%5EDJI/history/
4. Wall Street Journal – “Stock Market Today: Dow Climbs; SpaceX Overtakes Amazon Market Cap — Live Updates”
   https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-06-16-2026
5. Federal Reserve Coverage – “What to Expect in Markets This Week: Kevin Warsh Leads His First Fed Meeting” (Investopedia)
   https://www.investopedia.com/what-to-expect-in-markets-this-week-kevin-warsh-leads-his-first-fed-meeting-11995270
6. City National Bank – “Market Pulse: What’s Behind Friday’s Sell-Off and What Investors Should Know”
   https://www.citynational.com/post/whats-behind-sell-off-what-investors-should-know-june-2026
7. Keel Point – “Market Recap – June 15, 2026”
   https://keelpoint.com/insights/market-recap-june-15-2026/
8. WSJ – Dow Jones Industrial Average (DJIA) Quote and Historical Prices Page
   https://www.wsj.com/market-data/quotes/index/DJIA
9. WSJ – Nasdaq Composite Index (COMP) Historical Prices
   https://www.wsj.com/market-data/quotes/index/COMP/historical-prices
10. YouTube/Bloomberg – SpaceX Rally and Post‑IPO Commentary
    https://www.youtube.com/watch?v=0HF9WVx594U
11. YouTube/Bloomberg – “SpaceX Set for More Than 50% Jump in Just Three Sessions”
    https://www.youtube.com/watch?v=Y6QCeHOVZdI